The protocol of INTRALINK 40 mg/2ml provides for a cycle of 3 weekly injections to determine the attenuation of pain and swelling and regain joint function.

INTRALINK features excellent tolerability and acts only at the level of the joint into which it is injected without exercising any systemic action.